Skip to main content Skip to section navigation Skip to footer
chevron_leftBack to www.corbuspharma.com
Corbus Pharmaceuticals Holdings, Inc. IR Overview
  • Investors
  • Presentations
  • Analyst Coverage
  • News / Events
    • Press Releases
    • Events
  • Company Information
    • Profile
    • IR Contacts
    • FAQ
  • Financial Information
    • Financial Results
  • Stock Data
    • Quote and Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • chevron_leftBack to www.corbuspharma.com

Press Releases

News / Events

News / Events

  • Press Releases
  • Events
Feb 14, 2025 • 7:30 am EST
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025
Feb 11, 2025 • 7:30 am EST
Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GU
Jan 28, 2025 • 8:00 am EST
Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference
Jan 8, 2025 • 8:00 am EST
Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025
Jan 6, 2025 • 8:00 am EST
Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 9, 2024 • 7:00 am EST
Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors
Dec 3, 2024 • 7:00 am EST
FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer
Nov 21, 2024 • 8:00 am EST
Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference
Nov 12, 2024 • 8:00 am EST
Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Nov 7, 2024 • 7:00 am EST
Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 29
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
©2025 Corbus Pharmaceuticals Holdings, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement